Hepatitis E virus prevalence among HIV-2 infected individuals in central Portugal

Eur J Clin Microbiol Infect Dis. 2024 Dec;43(12):2473-2476. doi: 10.1007/s10096-024-04959-9. Epub 2024 Oct 12.

Abstract

To date, no studies comparing the prevalence of hepatitis E virus (HEV) infection between the general and human immunodeficiency virus 2 (HIV-2) populations are available. With the purpose of filling this gap, this prevalence was assessed in the HIV-2 population from central Portugal. HEV seropositivity was 19.4%, which did not differ significantly from that found in the matched control population, and was not associated with CD4 cell count, HIV-2 viral load, and geographic origin or travel history to regions considered highly endemic for HEV. The results suggest that HIV-2 is not a risk factor for HEV infection, neither for an increased occurrence of chronic HEV infection.

Keywords: HEV; HIV-2; Portugal; Prevalence.

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Coinfection / epidemiology
  • Coinfection / virology
  • Female
  • HIV Infections* / epidemiology
  • HIV Infections* / virology
  • HIV-2*
  • Hepatitis Antibodies / blood
  • Hepatitis E virus* / immunology
  • Hepatitis E* / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Portugal / epidemiology
  • Prevalence
  • Risk Factors
  • Seroepidemiologic Studies
  • Viral Load

Substances

  • Hepatitis Antibodies